Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo Nordisk clarifies Human Mixtard penfill to be replaced with injectables: Our Bureau, Bengaluru Wednesday, April 23, 2025, 13:30 Hrs [IST] Denmark-based global pharma major, N ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

The global insulin delivery pens market size is predicted to increase from USD 25,578 million in 2025 and is anticipated to ...

Novo Nordisk ... people needing insulin still had multiple options available in the country. Diabetologist V Mohan said that people who were using the more expensive pen device could shift ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Two prefilled, disposable insulin pen devices were used: InnoLet and FlexPen (Novo Nordisk). Because the hospital has one preferred formulary manufacturer for insulin analogues, orders from ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.